Clarithromycin-Resistant Mycobacterium avium Is Still Susceptible to Treatment with Clarithromycin and Is Virulent in Mice

Resistance to clarithromycin in breakthrough Mycobacterium avium complex (MAC) isolates typically occurs 3 to 4 months after the initiation of monotherapy in bacteremic AIDS patients. It has been suggested that continuation of clarithromycin therapy still results in clinical and microbiological impr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bermudez, Luiz E., Nash, Kevin, Petrofsky, Mary, Young, Lowell S., Inderlied, Clark B.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90125/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10991834/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.10.2619-2622.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!